Voss Capital, LP's Form 4 filing
Rein Therapeutics, Inc. (RNTX) · filed Oct 28, 2025
- Accession no.
- 0000921895-25-002819
- Filed
- Oct 28, 2025, 6:45 PM ET
- Trade date
- Oct 24-28, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $423.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Voss Capital, LPCIK 0001730145 | 10% Owner |
| Voss Advisors GP, LLCCIK 0001798309 | 10% Owner |
| Cocke Travis W.CIK 0001798383 | 10% Owner |
| Voss Value-Oriented Special Situations Fund, LPCIK 0001863498 | 10% Owner |
| Voss Value Master Fund, LPCIK 0001969435 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2025 | Common Stock, $0.001 par value | PPurchaseAcquired | +30,176 | $1.39 | +$41,956.71 | 729,616 | Indirect | |
| Oct 27, 2025 | Common Stock, $0.001 par value | PPurchaseAcquired | +92,642 | $1.37 | +$126,919.54 | 822,258 | Indirect | |
| Oct 27, 2025 | Common Stock, $0.001 par value | PPurchaseAcquired | +4,840 | $1.37 | +$6,624.51 | 321,608 | Indirect | |
| Oct 28, 2025 | Common Stock, $0.001 par value | PPurchaseAcquired | +178,392 | $1.39 | +$247,964.88 | 500,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.